James Niedel - Net Worth and Insider Trading
James Niedel Net Worth
The estimated net worth of James Niedel is at least $1 Million dollars as of 2024-11-10. James Niedel is the Director of Chimerix Inc and owns about 1,046,082 shares of Chimerix Inc (CMRX) stock worth over $1 Million. Details can be seen in James Niedel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Niedel has not made any transactions after 2014-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Niedel
James Niedel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Niedel owns 7 companies in total, including Chimerix Inc (CMRX) , Aravive Inc (ARAV) , and Concert Pharmaceuticals Inc (CNCE) among others .
Click here to see the complete history of James Niedel’s form 4 insider trades.
Insider Ownership Summary of James Niedel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2014-09-11 | director & 10 percent owner |
| ARAV | Aravive Inc | 2014-03-20 | 10 percent owner |
| CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 10 percent owner |
 | | 2013-11-27 | other: Former 10% Beneficial Owner |
| | 2012-12-18 | 10 percent owner |
| | 2013-11-20 | other: Former 10% beneficial owner |
| | 2011-07-13 | 10 percent owner |
James Niedel Latest Holdings Summary
James Niedel currently owns a total of 1 stock. James Niedel owns 1,046,082 shares of Chimerix Inc (CMRX) as of September 11, 2014, with a value of $1 Million.
Latest Holdings of James Niedel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMRX | Chimerix Inc | 2014-09-11 | 1,046,082 | 0.98 | 1,025,160 |
Holding Weightings of James Niedel
James Niedel Form 4 Trading Tracker
According to the SEC Form 4 filings, James Niedel has made a total of 0 transactions in Chimerix Inc (CMRX) over the past 5 years. The most-recent trade in Chimerix Inc is the sale of 1,099,949 shares on September 11, 2014, which brought James Niedel around $32 Million.
Insider Trading History of James Niedel
- 1
James Niedel Trading Performance
James Niedel Ownership Network
Ownership Network List of James Niedel
Ownership Network Relation of James Niedel
James Niedel Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
James Niedel is the director & 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Chief Business Officer Michael T. Andriole , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, James Niedel made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 40,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 3,029 shares made by Michael T. Andriole .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 127,000 shares were bought by its insiders, resulting in a net purchase of 115,761 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
James Niedel Mailing Address
Above is the net worth, insider trading, and ownership report for James Niedel. You might contact James Niedel via mailing address: C/o Credit Suisse Private Equity Inc, 11 Madison Ave, New York Ny 10010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
